Medical News

Medical Marijuana Might Reduce Nerve Pain Among People Living With HIV/AIDS, Study Says

February 13, 2007

Medical marijuana might reduce the pain of peripheral neuropathy, a type of nerve damage, among people living with HIV/AIDS, according to a study published in the Feb. 13 issue of the journal Neurology, the Washington Post reports (Weiss, Washington Post, 2/13). Donald Abrams of the University of California-San Francisco and colleagues examined the effects of smoking medicinal marijuana among people living with HIV/AIDS during a two-year period beginning in May 2003, the San Francisco Chronicle reports (Russell, San Francisco Chronicle, 2/13). Researchers enrolled 50 HIV-positive participants who reported severe foot pain caused either by HIV/AIDS or their medications, according to the Post (Washington Post, 2/13). The participants each spent a week at a secure laboratory at San Francisco General Hospital and were required to stop marijuana use before the start of the study (San Francisco Chronicle, 2/13). The researchers measured baseline pain among the participants by asking them to rank their pain on a scale of one to 100 and by administering two standardized tests involving a small hot iron applied to the skin and hot chili pepper cream (Washington Post, 2/13). Twenty-five participants were randomly chosen to receive active marijuana cigarettes with 3.5% THC, the drug's active ingredient, and 25 received a placebo (San Francisco Chronicle, 2/13). The participants smoked three times daily -- at 8 a.m., 2 p.m. and 8 p.m. -- for five days (Washington Post, 2/13). The study found that after the first cigarette on the first day, at least 50% of participants who received active marijuana reported a 72% reduction in pain (San Francisco Chronicle, 2/13). The researchers recorded a 15% reduction in pain among those who received the placebo cigarette (Vesely, Oakland Tribune, 2/12). Over five days, the median reduction in pain reported by the active marijuana smokers was 34%, compared with 17% in the placebo group, the study found (San Francisco Chronicle, 2/13). The researchers took steps to ensure that the marijuana in the study -- which was grown on the government's official marijuana farm in Mississippi and stored in a locked freezer -- was not used for recreational purposes, according to the Post (Washington Post, 2/13).

Comments, Reaction
The results are "evidence, using the gold standard for clinical research, that cannabis has some medical benefits for a condition that can be severely debilitating," Abrams said (San Francisco Chronicle, 2/13). He added, "I think that there are people out there who say there is no evidence that marijuana is medicine, that this is all just a smoke screen." David Murray, chief scientist for the White House Office of National Drug Control Policy, said the physical pain of people living with HIV/AIDS is an issue of great concern. However, "this particular study is not terribly convincing" because of methodological problems, Murray said (Dunham, Reuters, 2/12). He added, "People who smoke marijuana are subject to bacterial infections in the lungs. Is this really what a physician who is treating someone with a compromised immune system wants to prescribe?" (Elias, AP/Casper Star-Tribune, 2/13). Barbara Roberts -- former interim associate deputy director in the Office of National Drug Control Policy and now with Americans for Safe Access -- said, "This should be a wake-up call for Congress to hold hearings to investigate the therapeutic use of cannabis and to encourage more research" (Washington Post, 2/13). Igor Grant -- director of the University of California Center for Medicinal Cannabis Research, which funded the study -- said that although the study's finding are "very promising," they are not definitive (San Francisco Chronicle, 2/13).

Online The study is available online.

Back to other news for February 13, 2007


Reprinted with permission from You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at The Kaiser Daily HIV/AIDS Report is published for, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2007 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.